Adverse events | Severity (grade) | Resources consumed for the management of the adverse event |
---|---|---|
Non-exposed group (n = 150) | ||
1. Dizziness after an error in taking AtriplaTM | 1 | - |
2. Neuropsychiatric: insomnia, anxiety, and abnormal dreams* | 1 | - |
Exposed group (n = 75) | ||
1. Neuropsychiatric: dizziness | 2 | - |
2. Neuropsychiatric: insomnia, abnormal dreams* | 2 | - |
3. Neuropsychiatric: depression, insomnia* | 1 | - |
4. Neuropsychiatric: insomnia | 2 | Infectious disease consult |
5. Diarrhoea | 2 | - |
6. Vomiting | 2 | - |
7. Hepatic toxicity | 4 | Specialist and nursing consults, hospital admissions, chest x-rays, abdominal ultrasound, and hepatic biopsy |
8. Neuropsychiatric: dizziness, insomnia, and abnormal dreams* | 2 | - |
9. Neuropsychiatric: insomnia, anxiety, loss of concentration, abnormal dreams, and HIV encephalopathy after stopping treatment* | 4 | Infectious disease consults, hospital admissions, cranial CAT scan, cerebral MRI, and lumbar puncture |
10. Neuropsychiatric: dizziness | 1 | - |
11. Psychiatric: depression, insomnia, anxiety, abnormal dreams, and hallucinations* | 3 | Emergency department admission, mental health consult |
12. Hepatic toxicity | 3 | Infectious disease consult, nursing, biochemistry, serology, and abdominal ultrasound |
13. Neuropsychiatric: dizziness, insomnia, headache, and abnormal dreams* | 2 | Infectious disease consult |
14. Diarrhoea | 2 | - |